Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 64 publications
B-cell depletion improves therapeutic index of combination checkpoint blockade in patients with advanced melanoma.
Journal: The Journal of clinical investigation
Published: August 25, 2026
First-in-child phase I trial of p-STAT3 inhibitor WP1066 in pediatric brain tumor patients.
Journal: JCI insight
Published: December 11, 2025
Early CD4+ T cell proliferation and chronic T cell engagement impact myeloma outcomes following T cell engager therapy.
Journal: The Journal of clinical investigation
Published: August 05, 2025
First-in-child phase I trial of p-STAT3 inhibitor WP1066 in pediatric brain tumor patients.
Journal: JCI insight
Published: April 24, 2025
High-Dimensional Protein Analysis Uncovers Distinct Immunologic and Stromal Features in Primary and Metastatic Pancreatic Ductal Adenocarcinoma.
Journal: Cancer research
Published: April 18, 2025
Immune-aging at diagnosis determines T-cell recovery in childhood leukemia survivors.
Journal: npj aging
Published: January 12, 2025
Immune-aging is linked to clinical malignancy, racial ancestry, and vaccine responses in myeloma.
Journal: Blood advances
Published: December 20, 2024
Plasma Cytokine and Chemokine Profiles Predict Efficacy and Toxicity of Anti-CD19 CAR-T Cell Therapy in Large B-Cell Lymphoma.
Journal: Clinical lymphoma, myeloma & leukemia
Published: October 24, 2024
Minority report on cancer immunotherapy: focus on elderly and other understudied populations.
Journal: Journal for immunotherapy of cancer
Published: October 06, 2024
Tregs protect against combination checkpoint blockade toxicity induced by Tph and B cell interactions.
Journal: The Journal of clinical investigation
Published: May 02, 2024
Clinical response and pathway-specific correlates following TIGIT-LAG3 blockade in myeloma: the MyCheckpoint randomized clinical trial.
Journal: Nature cancer
Published: November 20, 2023
Divergence of variant binding/neutralizing antibodies following SARS-CoV-2 booster vaccines in myeloma: Impact of hybrid immunity.
Journal: Research square
Published: October 04, 2023
Last Updated: 09/26/2026